Azienda Ospedaliera Universitaria Federico II

Napoli, Campania 80131

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Breast Tumor, Cancer of the Breast, Crohn Disease, Estrogen Receptor- Negative Breast Cancer, HER2- Negative Breast Cancer, Metastatic Breast Cancer, Progesterone Receptor- Negative Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer, Triple-negative Breast Cancer, Triple-negative Metastatic Breast Cancer

Studies at this site

• Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease — Stopped early
• Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) — Completed